Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)-Reference-Cited by-同舟云学术

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

Published:2022-12 Issue:12 Volume:28 Page:810-821
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Dioverti Veronica^ORCID,Boghdadly Zeinab El,Shahid Zainab,Waghmare Alpana,Abidi Maheen Z.,Pergam Steven,Boeckh Michael,Dadwal Sanjeet,Kamboj Mini,Seo Susan,Chemaly Roy F.,Papanicolaou Genovefa A.

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference104 articles.

1. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy;Camargo;Transpl Infect Dis,2021

2. Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients;Mushtaq;Transplant Cell Ther,2021

3. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey;Ljungman;Leukemia,2021

4. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study;Sharma;Lancet Haematol,2021

5. Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients;Waghmare;Biol Blood Marrow Transplant,2020

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era;International Journal of Infectious Diseases;2024-10

2. Navigating uncharted waters: assessing the impact of the COVID-19 pandemic on hematopoietic stem cell transplantation: challenges and innovations;Annals of Medicine & Surgery;2024-08-07

3. Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee;The Lancet Oncology;2024-08

4. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

5. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies;Transplantation and Cellular Therapy;2024-07